Hamish N M Ross

This inventor holds 3 USPTO granted patents. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2005-2012.

USPTO Granted Patents = 3

% Patents Active = 66.7

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)

Company Filing History:

3 out of 363

Ortho-Mcneil Pharmaceutical Corp.

patents

Years Active: 2005-2012

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8278268 - Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators (2012-10-02),

2. 8183213 - Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators (2012-05-22),

3. 6838442 - Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators (2005-01-04),

Title: The Innovative Journey of Hamish N M Ross

Introduction: Hamish N M Ross is a distinguished inventor based in Far Hills, NJ (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hamish N M Ross holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: Throughout his illustrious career, Hamish N M Ross has consistently pushed the boundaries of innovation, with a focus on developing cutting-edge technologies that have the potential to revolutionize industries.

Collaborations: Hamish N M Ross has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Hamish N M Ross stands as a beacon of innovation, inspiring others in the field with his inventive spirit and dedication to creating a better future through technology.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]